Mohamed
Asyut, 71511, Egypt
NCT Number: NCT03824314
The aim of this study is to compare the effects of intrathecal levobupivacaine plus midazolam and levobupivacaine plus fentanyl in patients undergoing caesarean section to get a prolonged postoperative analgesic effect and less side effects
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Phase 1
Asyut, 71511, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 ml of 0.5% isobaric levobupivacaine (10 mg) plus 0.5 ml midazolam (2 mg)will be given intrathecally in L3 and L4 space with 25 gauge Quincke spinal needle via midline approach in sitting position. On free flow of cerebrospinal fluid, study drug will be injected intrathecally . Patients will immediately turn to supine position
2 ml of 0.5% isobaric levobupivacaine (10 mg) plus 0.5 ml fentanyl (25 μg)will be given intrathecally in L3 and L4 space with 25 gauge Quincke spinal needle via midline approach in sitting position. On free flow of cerebrospinal fluid, study drug will be injected intrathecally . Patients will immediately turn to supine position
Time frame: 24-hour
pain will be evaluated using VAS score, every 30 min for 180 min then hourly for 12 h and thereafter every 3 hourly till 24 h of surgery in both groups. Rescue analgesia in the form of injection Ketorolac 30mg I.V when VAS >3 in both groups.
Time frame: 24-hour
total duration of sensory block (regression to S1 dermatome) will be noted
Looking for future studies?
Notify MeMohamed Abdelrady Mohamed
Other
Comparison of the Effect of Adding Midazolam Versus Fentanyl to Intrathecal Levobupivacaine in Patients Undergoing Caesarean Section
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06242756
Cesarean Section Complications
Calgary, Alberta, Canada
View Trial DetailsNCT06669156
Cesarean Section Complications, Cesarean Section Pain
Viborg, Region Midt, Denmark
View Trial DetailsNCT05840367
Cesarean Section Complications
Kolding, Denmark
View Trial DetailsNCT06970483
Cesarean Section Complications, Delivery Complication
Ankara, Turkey (Türkiye)
View Trial Details